Chronic pancreatitis: Diagnosis, classification, and new genetic developments

Citation
B. Etemad et Dc. Whitcomb, Chronic pancreatitis: Diagnosis, classification, and new genetic developments, GASTROENTY, 120(3), 2001, pp. 682-707
Citations number
241
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
GASTROENTEROLOGY
ISSN journal
00165085 → ACNP
Volume
120
Issue
3
Year of publication
2001
Pages
682 - 707
Database
ISI
SICI code
0016-5085(200102)120:3<682:CPDCAN>2.0.ZU;2-N
Abstract
The utilization of recent advances in molecular and genomic technologies an d progress in pancreatic imaging techniques provided remarkable insight int o genetic, environmental, immunologic, and pathobiological factors leading to chronic pancreatitis. Translation of these advances into clinical practi ce demands a reassessment of current approaches to diagnosis, classificatio n, and staging, We conclude that an adequate pancreatic biopsy must be the gold standard against which all diagnostic approaches are judged, Although computed tomography remains the initial test of choice for the diagnosis of chronic pancreatitis, the roles of endoscopic retrograde pancreatography, endoscopic ultrasonography, and magnetic resonance imaging are considered. Once chronic pancreatitis is diagnosed, proper classification becomes impor tant. Major predisposing risk factors to chronic pancreatitis may be catego rized as either (1) toxic-metabolic, (2) idiopathic, (3) genetic, (4) autoi mmune, (5) recurrent and severe acute pancreatitis, or (6) obstructive (TIG AR-O system), After classification, staging of pancreatic function, injury, and fibrosis becomes the next major concern, Further research is needed to determine the clinical and natural history of chronic pancreatitis develop ing in the context of various risk factors. New methods are needed for earl y diagnosis of chronic pancreatitis, and new therapies are needed to determ ine whether interventions will delay or prevent the progression of the irre versible damage characterizing end-stage chronic pancreatitis.